These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21381184)

  • 21. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
    JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant use in pregnancy and the risk of cardiac defects.
    Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
    N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.
    Engelstad HJ; Roghair RD; Calarge CA; Colaizy TT; Stuart S; Haskell SE
    Neonatology; 2014; 105(2):149-54. PubMed ID: 24356332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
    Pedersen LH; Henriksen TB; Vestergaard M; Olsen J; Bech BH
    BMJ; 2009 Sep; 339():b3569. PubMed ID: 19776103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio].
    Weisskopf E; Fumeaux CJ; Bickle Graz M; Harari MM; Epiney M; Tolsa CB; Rouiller S; Tolsa JF; Eap CB; Vial Y; Csajka C; Panchaud A
    Rev Med Suisse; 2016 Mar; 12(510):561-6. PubMed ID: 27149719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
    Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
    N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.
    Reefhuis J; Devine O; Friedman JM; Louik C; Honein MA;
    BMJ; 2015 Jul; 351():h3190. PubMed ID: 26156519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
    Lam D; Gorman DA; Patten S; Pringsheim T
    Paediatr Drugs; 2013 Aug; 15(4):319-27. PubMed ID: 23529865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis.
    Brown HK; Hussain-Shamsy N; Lunsky Y; Dennis CE; Vigod SN
    J Clin Psychiatry; 2017 Jan; 78(1):e48-e58. PubMed ID: 28129495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
    Zoega H; Kieler H; Nørgaard M; Furu K; Valdimarsdottir U; Brandt L; Haglund B
    PLoS One; 2015; 10(12):e0144474. PubMed ID: 26657647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014).
    Petersen JM; Esposito DB; Werler MM
    Arch Womens Ment Health; 2021 Feb; 24(1):155-164. PubMed ID: 32222834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.
    Palmsten K; Hernández-Díaz S; Huybrechts KF; Williams PL; Michels KB; Achtyes ED; Mogun H; Setoguchi S
    BMJ; 2013 Aug; 347():f4877. PubMed ID: 23965506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
    Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
    PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of SSRIs during pregnancy: a controlled study.
    Altamura AC; De Gaspari IF; Rovera C; Colombo EM; Mauri MC; Fedele L
    Hum Psychopharmacol; 2013 Jan; 28(1):25-8. PubMed ID: 23166037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
    Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
    Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.